Genetype for Breast Cancer commissioned-Sales start Q1 2020
Filed with ASX · · 2 pages · English
Genetic Technologies Limited on 6ix
Story so far
Earlier from Genetic Technologies
- Response to Appendix 3Y Query
- Non-Renounceable Rights Issue
- Director Resignation
- Collaboration Agreement signed between GTG and TGen
- Reinstatement to Official Quotation
Later from Genetic Technologies
- Form F-1 Prospectus SEC Filing
- Updated Form F-1 Prospectus SEC Filing
- Breast Cancer Test US Sales Update
- Half Yearly Report and Accounts
- Receipt of Delisting Notification Letter from Nasdaq
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies